BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, January 19, 2026
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for July 29, 2025

July 29, 2025
Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Chengdu Kanghua Biological.
Read More

Other news to note for July 28, 2025

July 28, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Angiodynamics, Aptitude Medical, Carenexa, Longhorn, Matrix Medical, Molecular Testing Labs, MTL, Promega, Renovorx.
Read More

Other news to note for July 28, 2025

July 28, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Indivior, Klotho, Liminatus, Revolution.
Read More

Other news to note for July 25, 2025

July 25, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bio-Techne, Exactech, Fineheart, Healtharc, Medin, Patchrx, Patch Technologies, Spear Bio, Straits Orthopaedics.
Read More

Other news to note for July 25, 2025

July 25, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3Sbio, Bavarian Nordic, Gate Bioscience, Genentech, Eli Lilly, Kling Bio, Matchpoint, Novartis, Pfizer, Roche, Rocket, Sanofi, Verve.
Read More

Other news to note for July 24, 2025

July 24, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Intervenn Biosciences, Memed, Philips.
Read More

Other news to note for July 24, 2025

July 24, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arrowhead, Crossbow, Sarepta.
Read More

Other news to note for July 24, 2025

July 24, 2025
Additional early-stage research and drug discovery news in brief, from: Realta Life Sciences.
Read More

Other news to note for July 23, 2025

July 23, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: BD, Castle Biosciences, Heartflow.
Read More

Other news to note for July 23, 2025

July 23, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Astrazeneca, Biogen, Chengdu Kanghua, Hoth, Novo Nordisk.
Read More
Previous 1 2 … 24 25 26 27 28 29 30 31 32 … 1386 1387 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 16, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 16, 2026.
  • SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

    BioWorld Science
    Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
  • Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

    BioWorld
    With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
  • Illustration of human body surrounded by DNA, cell and drug icons

    Cell/gene therapy sector now sustainable; China competition mounting

    BioWorld
    There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing